Buy or sell 4D Molecular Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Request Access
View More Companies

4D Molecular Therapeutics Stock

4D Molecular Therapeutics’ mission is to design and develop transformative gene therapy products using our proprietary.

About 4D Molecular Therapeutics Stock

4D Molecular Therapeutics, we are unlocking the full potential of the gene therapy field. Our customized AAV vectors can deliver genes to any cell in the body to eradicate disease.

Funding History

August 2015$7.0M
September 2017$3.0M

Management

Co-Founder

David Schaffer

COO

Anthony Davies

Co-Founder, President & CEO

David Kirn

Press

Other Companies

GenePartner Logo
Learn More
Learn More
GenePartner
Gene matching service
12Age (years)
$0Total Funding
Magenta Therapeutics Logo
Learn More
Learn More
Magenta Therapeutics
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.
4Age (years)
$151MTotal Funding
Nabi Biopharmaceuticals Logo
Learn More
Learn More
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals develops preventive measures and treatments for diseases.
53Age (years)
$10.0MTotal Funding
Recursion Pharmaceuticals Logo
Learn More
Learn More
Recursion Pharmaceuticals
Automated drug discovery platform
6Age (years)
$516MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from 4D Molecular Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo